April Slee

4.3k total citations · 1 hit paper
99 papers, 3.0k citations indexed

About

April Slee is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, April Slee has authored 99 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 30 papers in Cardiology and Cardiovascular Medicine and 28 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in April Slee's work include Diabetes Treatment and Management (16 papers), Atrial Fibrillation Management and Outcomes (15 papers) and Anesthesia and Pain Management (11 papers). April Slee is often cited by papers focused on Diabetes Treatment and Management (16 papers), Atrial Fibrillation Management and Outcomes (15 papers) and Anesthesia and Pain Management (11 papers). April Slee collaborates with scholars based in United States, United Kingdom and Canada. April Slee's co-authors include Ashutosh Tewari, Prasanna Sooriakumaran, Usha Seshadri‐Kreaden, D. Blöch, Peter Wiklund, Santica M. Marcovina, Kevin D. O’Brien, Paulina Bondaronek, Neil A. Hanson and Nick Freemantle and has published in prestigious journals such as The Lancet, Circulation and Blood.

In The Last Decade

April Slee

91 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Positive Surgical Margin and Perioperative Complication Rates of Primary Surgical Treatments for Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Retropubic, Laparoscopic, and Robotic Prostatectomy

2012 361 citations April Slee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
April Slee United States	26	1.3k	778	539	494	329	99	3.0k
Lynn Shemanski United States	23	886 0.7×	1.7k 2.2×	934 1.7×	337 0.7×	485 1.5×	30	3.7k
Koichi Kozaki Japan	34	917 0.7×	1000 1.3×	512 0.9×	543 1.1×	423 1.3×	129	3.7k
Xiaoli Zhang China	28	418 0.3×	647 0.8×	317 0.6×	322 0.7×	437 1.3×	170	2.2k
David Gaist Denmark	42	884 0.7×	919 1.2×	418 0.8×	285 0.6×	816 2.5×	149	5.6k
Wenquan Niu China	32	488 0.4×	605 0.8×	392 0.7×	605 1.2×	277 0.8×	191	3.1k
Kyle Rudser United States	31	546 0.4×	389 0.5×	428 0.8×	454 0.9×	306 0.9×	159	3.9k
Scott Segal United States	32	1.3k 1.0×	638 0.8×	301 0.6×	205 0.4×	186 0.6×	130	3.2k
Barbara Kollerits Austria	32	834 0.7×	522 0.7×	391 0.7×	384 0.8×	693 2.1×	73	3.9k
Christel Renoux Canada	30	271 0.2×	842 1.1×	266 0.5×	681 1.4×	331 1.0×	117	3.7k
John Orazem United States	24	700 0.6×	338 0.4×	708 1.3×	404 0.8×	373 1.1×	45	3.2k

Countries citing papers authored by April Slee

Since Specialization

Citations

This map shows the geographic impact of April Slee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Slee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Slee more than expected).

Fields of papers citing papers by April Slee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April Slee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Slee. The network helps show where April Slee may publish in the future.

Co-authorship network of co-authors of April Slee

This figure shows the co-authorship network connecting the top 25 collaborators of April Slee. A scholar is included among the top collaborators of April Slee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April Slee. April Slee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grimm, Marc‐Oliver, Jens Bedke, Wael Khoder, et al.. (2025). Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa. Annals of Oncology. 36(8). 988–998. 1 indexed citations

Sharma, Abhinav, Adeera Levin, Harpreet S. Bajaj, et al.. (2024). Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association. 13(3). e031586–e031586. 1 indexed citations

Saksena, Sanjeev & April Slee. (2024). Rate Versus Rhythm Control for Atrial Fibrillation with Heart Failure. Cardiac Electrophysiology Clinics. 17(1). 19–41. 1 indexed citations

O’Reilly, Maeve, et al.. (2024). Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival. Clinical Nutrition ESPEN. 62. 206–215. 5 indexed citations

Slee, April, et al.. (2023). Investigating the prevalence of malnutrition, sarcopenia and frailty and the association between in different care settings of older adults. Clinical Nutrition ESPEN. 58. 715–716. 1 indexed citations

Sridhar, Vikas S., Brendon L. Neuen, Robert A. Fletcher, et al.. (2023). Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials. Diabetes Obesity and Metabolism. 25(8). 2331–2339. 5 indexed citations

Saksena, Sanjeev, April Slee, Andrea Natale, et al.. (2023). Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score–Matched Analysis of the TOPCAT Americas Trial. EP Europace. 25(5). 15 indexed citations

Gwathmey, Frank W., et al.. (2022). Pericapsular nerve group (PENG) block for hip arthroscopy: a randomized, double-blinded, placebo-controlled trial. Regional Anesthesia & Pain Medicine. 47(12). 728–732. 14 indexed citations

Hood, Anna, Jennifer Murphy, April Slee, et al.. (2021). Attitudes About COVID-19 and Health (ATTACH): Online Survey and Mixed Methods Study. JMIR Mental Health. 8(10). e29963–e29963. 2 indexed citations

10.

Marwali, Eva Miranda, et al.. (2021). Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary Bypass. Pediatric Cardiology. 43(4). 726–734. 3 indexed citations

11.

Piva, Simone, Robert M DiBlasi, April Slee, et al.. (2021). Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study. Respiratory Research. 22(1). 20–20. 51 indexed citations

12.

Weir, Matthew R., April Slee, Tao Sun, et al.. (2020). Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program. Clinical Kidney Journal. 14(5). 1396–1402. 19 indexed citations

13.

Bondaronek, Paulina, April Slee, Fiona Hamilton, & Elizabeth Murray. (2019). Relationship between popularity and the likely efficacy: an observational study based on a random selection on top-ranked physical activity apps. BMJ Open. 9(11). e027536–e027536. 5 indexed citations

14.

Cai, Jennifer, Linda M. Delahanty, Sydney Akapame, April Slee, & Shana Traina. (2018). Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials. Patient. 11(3). 341–352. 9 indexed citations

15.

Tóth, Peter P., Steven R. Jones, April Slee, et al.. (2018). Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial. Journal of clinical lipidology. 12(3). 741–747.e11. 4 indexed citations

16.

Slee, April, Jamie M. Kawadler, David C. Rees, et al.. (2017). Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort). Blood. 130. 3537–3537. 4 indexed citations

17.

Traina, Shana, April Slee, Suzy Van Sanden, & Joris Diels. (2017). An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin. Diabetes Therapy. 9(1). 125–140.

18.

Traina, Shana, Robert Guthrie, & April Slee. (2014). The Impact of Weight Loss on Weight-related Quality of Life and Health Satisfaction: Results From a Trial Comparing Canagliflozin With Sitagliptin in Triple Therapy Among People With Type 2 Diabetes. Postgraduate Medicine. 126(3). 7–15. 26 indexed citations

19.

Neslusan, C., et al.. (2014). The association of health-related quality of life (HRQOL) and achievement of disease management goals in the treatment of type 2 diabetes mellitus (T2DM). Value in Health. 17(3). A257–A257. 1 indexed citations

20.

Saksena, Sanjeev, April Slee, Albert L. Waldo, et al.. (2011). Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Journal of the American College of Cardiology. 58(19). 1975–1985. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact